These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3227054

  • 1. Haloperidol plasma level after a test dose as predictor for the clinical response to treatment in acute schizophrenic patients.
    Louza Neto MR, Müller-Spahn F, Rüther E, Scherer J.
    Pharmacopsychiatry; 1988 Sep; 21(5):226-31. PubMed ID: 3227054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
    Meco G, Casacchia M, Attenni M, Iafrate A, Castellana F, Ecari U.
    Acta Psychiatr Belg; 1983 Sep; 83(1):57-68. PubMed ID: 6613612
    [Abstract] [Full Text] [Related]

  • 5. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK, Hubbard JW, Marder SR, Marshall BD, Van Putten T.
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Haloperidol: therapeutic window in schizophrenia.
    Palao DJ, Arauxo A, Brunet M, Bernardo M, Haro JM, Ferrer J, Gonzalez-Monclus E.
    J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684
    [Abstract] [Full Text] [Related]

  • 9. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G, Safadi G, Beauclair L.
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
    Khot V, DeVane CL, Korpi ER, Venable D, Bigelow LB, Wyatt RJ, Kirch DG.
    J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
    [Abstract] [Full Text] [Related]

  • 13. Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients.
    Ereshefsky L, Davis CM, Harrington CA, Jann MW, Browning JL, Saklad SR, Burch NR.
    J Clin Psychopharmacol; 1984 Jun; 4(3):138-42. PubMed ID: 6736273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN, Korpi ER, Kirch DG.
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [Abstract] [Full Text] [Related]

  • 16. Pimozide versus Haloperidol in acute schizophrenia. A double blind controlled study.
    Haas S, Beckmann H.
    Pharmacopsychiatria; 1982 Mar; 15(2):70-4. PubMed ID: 7043498
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic protocol for predicting plasma haloperidol concentrations.
    Miller DD, Perry PJ, Kelly MW, Coryell WH, Arndt SV.
    J Clin Psychopharmacol; 1990 Jun; 10(3):207-12. PubMed ID: 2376619
    [Abstract] [Full Text] [Related]

  • 18. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
    Volavka J, Cooper TB, Czobor P, Meisner M.
    Psychopharmacol Bull; 1996 Jun; 32(1):75-9. PubMed ID: 8927679
    [Abstract] [Full Text] [Related]

  • 19. Effective clinical response at low plasma levels of haloperidol in Japanese schizophrenics with acute psychotic state.
    Jibiki I, Kubota T, Fujimoto K, Sakamoto H, Hasegawa M, Furuta H, Yamaguchi N.
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):627-9. PubMed ID: 8301878
    [No Abstract] [Full Text] [Related]

  • 20. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I, Levine S.
    Biol Psychiatry; 1995 Aug 01; 38(3):198-200. PubMed ID: 7578667
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.